Mantovani, G., Maccio, A., Madeddu, C., Gramignano, G., Serpe, R., Massa, E., Dessi, M., Tanca, F
Semaglutide has been approved for chronic weight management in adults with obesity or overweight individuals with at least one weight-related condition (such as hypertension or dyslipidemia)
It has a long history of use, a clean safety profile, and FDA approval for pediatric GH deficiency
Already ordering other products
GLP-1 medications require ongoing monitoring for side effects, metabolic changes, and dose adjustments
Always consult your doctor or another qualified medical provider with any questions you may have regarding a medical condition or treatment options